The electrocardiographic response to amyl nitrite inhalation was correlated with treadmill stress testing in 6i patients. Eleven 
Amyl nitrite has long been recognized to be an effective agent in the treatment of angina pectoris (Brunton, I867) . Its effects on the phonocardiogram and its haemodynamic actions have been well studied and provide useful diagnostic information in a variety of cardiac lesions (Beck et al., I96I; Cohn, Flamm, and Hancock, I968; Perloff et al., I963) . Electrocardiographic alterations of ,-several types after amyl nitrite inhalation have been described (Goldberger, 1945;  Myburgh, I969), and it has been suggested that the appearance of these changes may indicate the presence of coronary heart disease (Contro, Haring, and Goldstein, I952; Varela de Seijas Aguilar et al., I953; Rizzon, Lovreglio, ,and Bacca, I963) . These (Fig. i-6 ). Of these ii patients, 8 had coronary artery disease, shown angiographically ( Fig. I-5 ). One patient had aortic stenosis with normal coronary arteries, one suffered from clinically typical angina pectoris with angiographically demonstrated normal coron-*ary arteries (Fig. 4) , and one had systemic lupus erythematosus (Fig. 6 ). Of these ii patients, I0 also had positive treadmill tests; one had 'J' depression only on treadmill testing (Fig. 3) .
Three additional patients developed 'J'-point depression after amyl nitrite, as well as on treadmill testing (Fig. 7) .
Atrial pacing studies were performed on 4 patients: one with ischaemic ST depressions induced by both amyl nitrite and treadmill tests (Fig. 4) ; one with 'J' depression on both amyl nitrite and treadmill test (Fig. 7) (Fig. 8-I I) . The mean ages and sex distribution within these two groups were not statistically different. Before amyl nitrite, there were no significant differences between the two groups in heart rate and systolic and diastolic blood pressure. After amyl nitrite inhalation, the Group B patients developed significantly faster maximal heart rates and lower systolic and diastolic blood pressures. The product of heart rate and systolic blood pressure, however, was not significantly different between the two groups, either before or after amyl nitrite.
Three patients with positive amyl nitrite tests underwent repeat amyl nitrite testing while receiving oral propranolol. In all, the blood pressure changes were unaffected, but the mean maximal heart rate attained was reduced from 135 to III (I7% decline) while the patient was receiving propranolol. In I of these 3 patients, the repeat amyl nitrite test performed during the administration of propranolol became negative (Fig. 4) , while in a second, the repeat test was equivocal (Fig. 5) .
Sublingual nitroglycerin was administered to IO standing patients with coronary artery disease, including 2 with positive amyl nitrite tests. In no instance did the blood pressure or heart rate changes of nitroglycerin approach those induced by amyl nitrite, and no ischaemic electrocardiographic changes occurred. (Mason and Braunwald, :'I965) . A reflex venoconstriction and tachycardia ensue, and the cardiac output rises rapidly because of the decreased systemic resistance (afterload) and increased venous return (pre-load), the latter resulting from intense venoconstriction. However, the tendency for the reflex venoconstriction to in-X)crease the pre-load and work of the ventricle is overbalanced by the greater effect of the reduced afterload; this results in overall reductions of intraventricular systolic pressure and volume and diminished myocardial tension and oxygen demand (Mason, Zelis, and Amsterdam, I97I) . This is the physiological basis for the use of amyl nitrite in the relief of angina pectoris. On the other hand, the fall in diastolic blood pressure results in a conspicuous fall in coronary perfusion pressure. At the same time, tachycardia results in an abbreviation of diastole and coronary blood flow. These factors probably assume additional importance in a diseased coronary vessel with critical luminal stenosis. It has, therefore, been suggested that the amyl nitrite induced rapid fall in blood pressure might, paradoxically, worsen ischaemia in instances where the decline in coronary blood flow is greater than the decrease in myocardial oxygen need (Mason et al., I97I) .
This investigation presents evidence to support this hypothesis. It is also supported by comparison of the Group B patients (positive amyl nitrite tests) with Group A patients (coronary artery disease, positive treadmill test, negative amyl nitrite test) with regard to amyl nitrite induced heart rate and blood pressure chahge. These changes were significantly greater in the patients with positive amyl nitrite tests than those with negative tests. On the other hand, the product of systolic blood pressure and heart rate -a rough indicator of myocardial oxygen requirements -declined about equally in both groups. Thus, amyl nitrite appears to have reduced myocardial oxygen demand to the same degree in both groups of patients; those who develop greater hypotension and tachycardia with the drug presumably incur a fall in coronary blood flow which transiently outweighs the reduced myocardial oxygen demand and results in a temporary period of myocardial ischaemia.
FIG. 9 Systolic blood pressure before and after amyl nitrite inhalation in erect patients. Group B patients achieve a significantly lower minimal systolic blood pressure after amyl nitrite. 3) and propranolol therapy (Fig. 4 and 5 
